Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension

David J.R. Fulton, Xueyi Li, Zsuzsanna Bordan, Yusi Wang, Keyvan Mahboubi, R. Daniel Rudic, Stephen Haigh, Feng Chen, Scott A. Barman

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Significance: Pulmonary arterial hypertension (PAH) is a progressive disease arising from the narrowing of pulmonary arteries (PAs) resulting in high pulmonary arterial blood pressure and ultimately right ventricle (RV) failure. A defining characteristic of PAH is the excessive and unrelenting inward remodeling of PAs that includes increased proliferation, inflammation, and fibrosis. Critical Issues: There is no cure for PAH nor interventions that effectively arrest or reverse PA remodeling, and intensive research over the past several decades has sought to identify novel molecular mechanisms of therapeutic value. Recent Advances: Galectin-3 (Gal-3) is a carbohydrate-binding lectin remarkable for its chimeric structure, composed of an N-terminal oligomerization domain and a C-terminal carbohydrate-recognition domain. Gal-3 has been identified as a regulator of numerous changes in cell behavior that contributes to aberrant PA remodeling, including cell proliferation, inflammation, and fibrosis, but its role in PAH has remained poorly understood until recently. In contrast, pathological roles for Gal-3 have been proposed in cancer and inflammatory and fibroproliferative disorders, such as pulmonary vascular and cardiac fibrosis. Herein, we summarize the recent literature on the role of Gal-3 in the development of PAH. We provide experimental evidence supporting the ability of Gal-3 to influence reactive oxygen species production, NADPH oxidase enzyme expression, and redox signaling, which have been shown to contribute to both vascular remodeling and increased pulmonary arterial pressure. Future Directions: While several preclinical studies suggest that Gal-3 promotes hypertensive pulmonary vascular remodeling, the clinical significance of Gal-3 in human PAH remains to be established. Antioxid. Redox Signal. 00, 000-000.

Original languageEnglish (US)
Pages (from-to)1053-1069
Number of pages17
JournalAntioxidants and Redox Signaling
Volume31
Issue number14
DOIs
StatePublished - Nov 10 2019

Fingerprint

Galectin 3
Pulmonary Hypertension
Reactive Oxygen Species
Fibrosis
Inflammation
Pulmonary Artery
Lung
Oxidation-Reduction
Arterial Pressure
Carbohydrates
NADPH Oxidase
Oligomerization
Lectins
Blood pressure
Cell proliferation
Heart Ventricles
Blood Vessels
Cell Proliferation
Enzymes
Research

Keywords

  • fibrosis
  • galectin-3
  • inflammation
  • PAH
  • pulmonary hypertension
  • reactive oxygen species
  • vascular remodeling

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Galectin-3 : A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension. / Fulton, David J.R.; Li, Xueyi; Bordan, Zsuzsanna; Wang, Yusi; Mahboubi, Keyvan; Rudic, R. Daniel; Haigh, Stephen; Chen, Feng; Barman, Scott A.

In: Antioxidants and Redox Signaling, Vol. 31, No. 14, 10.11.2019, p. 1053-1069.

Research output: Contribution to journalReview article

Fulton, David J.R. ; Li, Xueyi ; Bordan, Zsuzsanna ; Wang, Yusi ; Mahboubi, Keyvan ; Rudic, R. Daniel ; Haigh, Stephen ; Chen, Feng ; Barman, Scott A. / Galectin-3 : A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension. In: Antioxidants and Redox Signaling. 2019 ; Vol. 31, No. 14. pp. 1053-1069.
@article{7c768d0f26c4439097191fd715517580,
title = "Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension",
abstract = "Significance: Pulmonary arterial hypertension (PAH) is a progressive disease arising from the narrowing of pulmonary arteries (PAs) resulting in high pulmonary arterial blood pressure and ultimately right ventricle (RV) failure. A defining characteristic of PAH is the excessive and unrelenting inward remodeling of PAs that includes increased proliferation, inflammation, and fibrosis. Critical Issues: There is no cure for PAH nor interventions that effectively arrest or reverse PA remodeling, and intensive research over the past several decades has sought to identify novel molecular mechanisms of therapeutic value. Recent Advances: Galectin-3 (Gal-3) is a carbohydrate-binding lectin remarkable for its chimeric structure, composed of an N-terminal oligomerization domain and a C-terminal carbohydrate-recognition domain. Gal-3 has been identified as a regulator of numerous changes in cell behavior that contributes to aberrant PA remodeling, including cell proliferation, inflammation, and fibrosis, but its role in PAH has remained poorly understood until recently. In contrast, pathological roles for Gal-3 have been proposed in cancer and inflammatory and fibroproliferative disorders, such as pulmonary vascular and cardiac fibrosis. Herein, we summarize the recent literature on the role of Gal-3 in the development of PAH. We provide experimental evidence supporting the ability of Gal-3 to influence reactive oxygen species production, NADPH oxidase enzyme expression, and redox signaling, which have been shown to contribute to both vascular remodeling and increased pulmonary arterial pressure. Future Directions: While several preclinical studies suggest that Gal-3 promotes hypertensive pulmonary vascular remodeling, the clinical significance of Gal-3 in human PAH remains to be established. Antioxid. Redox Signal. 00, 000-000.",
keywords = "fibrosis, galectin-3, inflammation, PAH, pulmonary hypertension, reactive oxygen species, vascular remodeling",
author = "Fulton, {David J.R.} and Xueyi Li and Zsuzsanna Bordan and Yusi Wang and Keyvan Mahboubi and Rudic, {R. Daniel} and Stephen Haigh and Feng Chen and Barman, {Scott A.}",
year = "2019",
month = "11",
day = "10",
doi = "10.1089/ars.2019.7753",
language = "English (US)",
volume = "31",
pages = "1053--1069",
journal = "Antioxidants and Redox Signaling",
issn = "1523-0864",
publisher = "Mary Ann Liebert Inc.",
number = "14",

}

TY - JOUR

T1 - Galectin-3

T2 - A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension

AU - Fulton, David J.R.

AU - Li, Xueyi

AU - Bordan, Zsuzsanna

AU - Wang, Yusi

AU - Mahboubi, Keyvan

AU - Rudic, R. Daniel

AU - Haigh, Stephen

AU - Chen, Feng

AU - Barman, Scott A.

PY - 2019/11/10

Y1 - 2019/11/10

N2 - Significance: Pulmonary arterial hypertension (PAH) is a progressive disease arising from the narrowing of pulmonary arteries (PAs) resulting in high pulmonary arterial blood pressure and ultimately right ventricle (RV) failure. A defining characteristic of PAH is the excessive and unrelenting inward remodeling of PAs that includes increased proliferation, inflammation, and fibrosis. Critical Issues: There is no cure for PAH nor interventions that effectively arrest or reverse PA remodeling, and intensive research over the past several decades has sought to identify novel molecular mechanisms of therapeutic value. Recent Advances: Galectin-3 (Gal-3) is a carbohydrate-binding lectin remarkable for its chimeric structure, composed of an N-terminal oligomerization domain and a C-terminal carbohydrate-recognition domain. Gal-3 has been identified as a regulator of numerous changes in cell behavior that contributes to aberrant PA remodeling, including cell proliferation, inflammation, and fibrosis, but its role in PAH has remained poorly understood until recently. In contrast, pathological roles for Gal-3 have been proposed in cancer and inflammatory and fibroproliferative disorders, such as pulmonary vascular and cardiac fibrosis. Herein, we summarize the recent literature on the role of Gal-3 in the development of PAH. We provide experimental evidence supporting the ability of Gal-3 to influence reactive oxygen species production, NADPH oxidase enzyme expression, and redox signaling, which have been shown to contribute to both vascular remodeling and increased pulmonary arterial pressure. Future Directions: While several preclinical studies suggest that Gal-3 promotes hypertensive pulmonary vascular remodeling, the clinical significance of Gal-3 in human PAH remains to be established. Antioxid. Redox Signal. 00, 000-000.

AB - Significance: Pulmonary arterial hypertension (PAH) is a progressive disease arising from the narrowing of pulmonary arteries (PAs) resulting in high pulmonary arterial blood pressure and ultimately right ventricle (RV) failure. A defining characteristic of PAH is the excessive and unrelenting inward remodeling of PAs that includes increased proliferation, inflammation, and fibrosis. Critical Issues: There is no cure for PAH nor interventions that effectively arrest or reverse PA remodeling, and intensive research over the past several decades has sought to identify novel molecular mechanisms of therapeutic value. Recent Advances: Galectin-3 (Gal-3) is a carbohydrate-binding lectin remarkable for its chimeric structure, composed of an N-terminal oligomerization domain and a C-terminal carbohydrate-recognition domain. Gal-3 has been identified as a regulator of numerous changes in cell behavior that contributes to aberrant PA remodeling, including cell proliferation, inflammation, and fibrosis, but its role in PAH has remained poorly understood until recently. In contrast, pathological roles for Gal-3 have been proposed in cancer and inflammatory and fibroproliferative disorders, such as pulmonary vascular and cardiac fibrosis. Herein, we summarize the recent literature on the role of Gal-3 in the development of PAH. We provide experimental evidence supporting the ability of Gal-3 to influence reactive oxygen species production, NADPH oxidase enzyme expression, and redox signaling, which have been shown to contribute to both vascular remodeling and increased pulmonary arterial pressure. Future Directions: While several preclinical studies suggest that Gal-3 promotes hypertensive pulmonary vascular remodeling, the clinical significance of Gal-3 in human PAH remains to be established. Antioxid. Redox Signal. 00, 000-000.

KW - fibrosis

KW - galectin-3

KW - inflammation

KW - PAH

KW - pulmonary hypertension

KW - reactive oxygen species

KW - vascular remodeling

UR - http://www.scopus.com/inward/record.url?scp=85066463388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066463388&partnerID=8YFLogxK

U2 - 10.1089/ars.2019.7753

DO - 10.1089/ars.2019.7753

M3 - Review article

C2 - 30767565

AN - SCOPUS:85066463388

VL - 31

SP - 1053

EP - 1069

JO - Antioxidants and Redox Signaling

JF - Antioxidants and Redox Signaling

SN - 1523-0864

IS - 14

ER -